CIK 0001810182 · Non-accelerated filer<br>Smaller reporting company
ALX ONCOLOGY HOLDINGS INC
Sign in to watch- Ticker
- ALXO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850642577
- Phone
- 650-466-7125
- Business address
- 323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,410
- in 2 filings
Net −$5,410. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-19 | Pons Jaume PRESIDENT & CSO | Sale | −1,326 | $1.15 | $2K | 579,388 |
| 2025-02-19 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Sale | −2,159 | $1.15 | $2K | 170,270 |
| 2025-01-21 | Hemrajani Rekha Director | Grant or award · Stock Option (right to buy) | +40,400 | 40,400 | ||
| 2025-01-21 | Garland J. Scott Director | Grant or award · Common Stock | +40,400 | 40,400 | ||
| 2025-01-21 | GOODMAN COREY S Director | Grant or award · Stock Option (right to buy) | +40,400 | 40,400 | ||
| 2025-01-21 | Takimoto Chris H Director | Grant or award · Common Stock (right to buy) | +40,400 | 40,400 | ||
| 2025-01-21 | Klencke Barbara Director | Grant or award · Stock Option (right to buy) | +40,400 | 40,400 | ||
| 2025-01-21 | Shantharam Harish Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2025-01-21 | Pinto Shelly SVP, FINANCE AND CAO | Grant or award · Employee Stock Option (right to buy) | +112,000 | 112,000 | ||
| 2025-01-21 | Sandler Alan B. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2025-01-21 | Pons Jaume PRESIDENT & CSO | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2025-01-21 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +478,000 | 478,000 | ||
| 2025-01-06 | Pinto Shelly Interim CFO | Sale | −2,221 | $1.80 | $4K | 87,902 |
| 2024-12-30 | Pinto Shelly Interim CFO | Sale | −1,426 | $1.58 | $2K | 90,123 |
| 2024-12-30 | Pons Jaume PRESIDENT & CSO | Sale | −10,796 | $1.58 | $17K | 580,714 |
| 2024-12-02 | Hemrajani Rekha Director | Purchase | +30,000 | $1.55 | $46K | 33,000 |
| 2024-12-02 | Pinto Shelly Interim CFO | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2024-12-02 | Lettmann Jason CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-11-18 | Sandler Alan B. Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2024-08-14 | Pinto Shelly SVP, FINANCE AND CAO | Sale | −564 | $2.58 | $1K | 91,549 |
Page 3 of 22 · 432 trades